Clinical Trial Update: Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating bevacizumab and triamcinolone for macular edema due to central retinal vein occlusion was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Avastin (bevacizumab)
• Kenalog (triamcinolone acetonide)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Macular Edema, Central Retinal Vein Occlusion | Phase 4 | Status: TERMINATED